Skip to search.
 FTSE 100 Up 0.42%
Streaming
Ticker Tape: On

More On BTGGF

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

BTG plc (BTGGF)

-Other OTC
9.16 Down 0.23(2.46%) 24 Apr 17:24
Add to Portfolio
Prev Close:9.39
Open:9.16
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:9.16 - 9.16
52wk Range:5.24 - 10.14
Volume:100
Avg Vol (3m):1,719
Market Cap:3.20b
P/E (ttm):88.92
EPS (ttm):0.10
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):0.50
P/S (ttm):8.39
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Mar-14) :14.14
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BTG plc, a specialist healthcare company, engages in developing and commercializing products targeting critical care, cancer, and varicose veins. It operates through three segments: Specialty Pharmaceuticals, Interventional Medicine, and Licensing... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback